BAY-73-6691

N/A

Report date: 2024/12/02 11:06:04
NME

Base Information

Drug NameBAY-73-6691
Drug Alias NameBAY-73-6691
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 9A inhibitors
TargetsPhosphodiesterase 9A
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A